We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Music-with-Movement Intervention for People With Early Dementia and Their Families

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01976832
Recruitment Status : Completed
First Posted : November 6, 2013
Last Update Posted : September 5, 2016
Sponsor:
Information provided by (Responsible Party):
Claudia K Y Lai, The Hong Kong Polytechnic University

Brief Summary:

This study intends to use music and movement (MWM) to reduce anxiety and behavioral symptoms of people with early dementia (PWD) and their family carers in the community. It also aims to examine whether MWM can enhance the sleep quality of PWD and their family caregivers and promote their well-being.

This is a mixed methods study with the quantitative paradigm being the main research approached used. The quantitative arm will be a randomized controlled trial (RCT). The qualitative arm will adopt a naturalistic approach through interviewing for data collection. Recruited subjects from the community centres of non-government organizations (NGOs) will be randomly allocated to the intervention and control group.

The outcome measures of the PWD will include Rating Anxiety in Dementia (RAID), Geriatric Depression Scale (GDS), Neuropsychiatric Inventory Questionnaire (NPI-Q), Pittsburgh Sleep Quality Index (PQSI), Quality of Life - Alzheimer's Disease (QOL-AD), Mini-Mental State Examination (MMSE), Revised Life Event Scale (RLES), Modified Brathel Index (MBI) and Non-pharmacological Therapy Experience Scale (NPTES), whereas the outcome measures of the family caregivers will be Patient Health Questionnaire 9 (PHQ-9), Generalized Anxiety Disorder 7 (GAD-7), Zarit Burden Scale (ZBD), Pittsburgh Sleep Quality Index (PSQI), Reverse Life event Scale (RLES), and World Health Organization Quality of Life-BREF (WHOQOL-BREF).

To address the research questions, data will be collected at baseline (T0), immediately post-intervention at 8-weeks (T1), and 8 post-intervention (T2). The qualitative arm of this study will contribute to the understanding of issues and effects of MWM as an intervention. Its finding will complement the results obtained from the RCT.


Condition or disease Intervention/treatment Phase
Dementia Anxiety Sleep Depression Quality of Life Behavioral: Music with movement Behavioral: Social interaction Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 95 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Music-with-Movement Intervention for People With Early Dementia and Their Families
Study Start Date : July 2014
Actual Primary Completion Date : May 2016
Actual Study Completion Date : August 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Music with movement
Participants in the intervention group will receive the intervention delivered by their family member according to the validated 8-weeks music with movement (MWM) intervention protocol.
Behavioral: Music with movement
Participants in the intervention group will receive the intervention delivered by their family member according to the validated 8-week music with movement (MWM) intervention protocol.

Active Comparator: Social interaction

The control group will receive a protocol for social interaction as the control condition, where caregivers were asked to discuss up to date news with PWeD.

The design of the control condition will be highly similar to the MWM protocol in terms of the frequency and duration of the sessions, the number of people involved, and the total intervention period.

Behavioral: Social interaction

The control group will receive a protocol for social interaction as the control condition, where caregivers were asked to discuss up to date news with PWeD.

The design of the control condition will be highly similar to the MWM protocol in terms of the frequency and duration of the sessions, the number of people involved, and the total intervention period.





Primary Outcome Measures :
  1. Change of Rating anxiety in Dementia (RAID) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1


Secondary Outcome Measures :
  1. Change of Geriatric Depression Scale (GDS) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  2. Change of Neuropsychiatric Inventory Questionnaire(NPI-Q) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  3. Change of Pittsburgh Sleep Quality Index (PQSI) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD and Caregivers of PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  4. Change of Quality of Life - Alzheimer's Disease (QOL-AD) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  5. Change of Patient Health Questionnaire 9 (PHQ-9) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For Caregivers of PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  6. Change of Zarit Burden Scale (ZBS) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For Caregivers of PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  7. Change of World Health Organization Quality of Life-BREF (WHOQOL-BREF) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For Caregivers of PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  8. Change of Generalized Anxiety Disorder 7 [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For Caregivers of PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  9. Change of Mini-Mental State Examination (MMSE) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  10. Change of Revised Life Event Scale (RLES) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD and Caregivers of PWD

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  11. Change of Lawton's Instrumental Activity of Daily Living (IADL) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1

  12. Change of Modified Barthel Index (MBI) [ Time Frame: At baseline (T0), immediately post-intervention at 8-weeks (T1), and 8-weeks post-intervention (T2) ]

    For PWD only

    Comparisons of changes of RAID will be considered as follows:

    1. T1 - T0
    2. T2 - T0
    3. T2 - T1


Other Outcome Measures:
  1. Change of Non-pharmacological Therapy Experience Scale (NPTES) [ Time Frame: once per month within the intervention period ]
    NPTES will be collected within the intervention period on several occasions. That is to say, to be obtained once per month between T0 to T1, and only for the intervention group. It is an observational tool intended for capturing the qualitative information during an intervention.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. PWD

    • Aged 65 or above
    • Community-dwelling
    • With early dementia [Clinical Dementia Rating (CDR) Scale scored between 0.5 to 1, denoting mild to early signs of cognitive impairment]
    • In a stable medical condition
    • Communicate in Cantonese
    • Has a family caregiver who is willing to participate in the study
  2. Family caregiver of the recruited PWD

    • Is the primary caregiver of the PWD (defined as the one in the family who is responsible for taking care of the PWD regardless of whether s/he is living together with the PWD in the same dwelling place. That is to say, him/herself considers self as the person responsible to provide needed care for the PWD; or other family members would expect him/her to perform or be responsible for main caregiving tasks needed by the PWD.)
    • Is related to the PWD and not a paid live-in care attendant
    • Paid caregiver is allow to assist the primary caregivers if he/she attended the MWM training, but can contribute no more than 50% of the delivery of intervention.
  3. Staff

    • Completed no less than 80% of the training program for delivery the MWM protocol
    • Has been involved in the delivery of the MWM intervention to the intervention group for at least one cycle of recruitment Note: staff recruitment as the informant of the qualitative arm of this study is also entirely voluntary.

Exclusion Criteria:

  1. PWD With acute exacerbation of chronic illnesses that affects the adherence of the MWM protocol, e.g., acute heart failure, relapse of acute depressive disorder unable to hear even with the use of hearing aids unable to sit independently for around 45 minutes
  2. Family caregivers of the recruited PWD

    - Nil

  3. Staff - Nil

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01976832


Locations
Layout table for location information
Hong Kong
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
Sponsors and Collaborators
The Hong Kong Polytechnic University
Investigators
Layout table for investigator information
Principal Investigator: Kam Yuk, Claudia Lai, PhD School of Nursing, The Hong Kong Polytechnic University
Principal Investigator: Shuk Ching, Jacqueline Ho, PhD School of Nursing, The Hong Kong Polytechnic University
Principal Investigator: Sze Ki, Daphne Cheung, PhD School of Nursing, The Hong Kong Polytechnic University
Publications of Results:
Layout table for additonal information
Responsible Party: Claudia K Y Lai, Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier: NCT01976832    
Other Study ID Numbers: 5-ZH96
First Posted: November 6, 2013    Key Record Dates
Last Update Posted: September 5, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders